Collaborating to conquer cancer: Lessons from our children

Journal of Clinical Oncology

Volumn 31, Issue 7, 2013, Pages 825-832

  Link, Michael P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRIZOTINIB;

ADVANCED CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILDHOOD CANCER; CHILDHOOD OBESITY; CLINICAL PRACTICE; CLINICAL PROTOCOL; EARLY DIAGNOSIS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; KIDNEY CARCINOMA; LIFESTYLE MODIFICATION; LUNG CANCER; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; NEUROBLASTOMA; PATIENT CARE; PATIENT COUNSELING; PHENOTYPE; PHILADELPHIA CHROMOSOME POSITIVE CELL; POLICY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION;

ADOLESCENT; ANNIVERSARIES AND SPECIAL EVENTS; ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; COOPERATIVE BEHAVIOR; COST CONTROL; EMPATHY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH POLICY; HUMANS; MALE; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE TEAM; PATIENT-CENTERED CARE; PEDIATRICS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; QUALITY OF LIFE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECEPTOR PROTEIN-TYROSINE KINASES; SOCIETIES, MEDICAL; SURVIVAL RATE;

EID: 84875734185     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.48.0293     Document Type: Review

References (28)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62:10-29, 2012.
2. Brody H: Medicine's ethical responsibility for health care reform: The top five list. N Engl J Med 362:283-285, 2010.
3. Schnipper LE, Smith TJ, Raghavan D, et al: American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: The top five list for oncology. J Clin Oncol 30:1715-1724, 2012.
4. American Society of Health-System Pharmacists: Drug shortages. http://www.ashp.org/shortages.
5. Link MP, Hagerty K, Kantarjian HM: Chemotherapy drug shortages in the United States: Genesis and potential solutions. J Clin Oncol 30:692-694, 2012.
6. Sledge GW Jr: The challenge and promise of the genomic era. J Clin Oncol 30:203-209, 2012.
7. Pinkel D: The Ninth Annual David Karnofsky Lecture: Treatment of acute lymphocytic leukemia. Cancer 43:1128-1137, 1979. (Pubitemid 9165433)
8. Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. N Engl J Med 350:1535-1548, 2004.
9. Hunger SP, Lu X, Devidas M, et al: Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the Children's Oncology Group. J Clin Oncol 30:1663-1669, 2012.
10. Schultz KR, Bowman WP, Aledo A, et al: Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A Children's Oncology Group study. J Clin Oncol 27:5175-5181, 2009.
11. Downing JR, Wilson RK, Zhang J, et al: The Pediatric Cancer Genome Project. Nat Genet 44: 619-622, 2012.
12. Schmidt ML, Lukens JN, Seeger RC, et al: Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 18:1260-1268, 2000. (Pubitemid 30159844)
13. Cohn SL, Pearson AD, London WB, et al: The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol 27:289-297, 2009.
14. Mullighan CG, Phillips LA, Su X, et al: Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322:1377- 1380, 2008. (Pubitemid 352775249)
15. Gerlinger M, Rowan AJ, Horswell S, et al: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883-892, 2012.
16. [No authors listed]: Stat bite: Average years of life lost from cancer. J Natl Cancer Inst 93:341, 2001.
17. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006. (Pubitemid 44547808)
18. O'Brien MM, Donaldson SS, Balise RR, et al: Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol 28:1232-1239, 2010.
19. Link MP, Donaldson SS, Berard CW, et al: Results of treatment of childhood localized non- Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 322:1169-1174, 1990. (Pubitemid 20137847)
20. Smith MA, Seibel NL, Altekruse SF, et al: Outcomes for children and adolescents with cancer: Challenges for the twenty-first century. J Clin Oncol 28:2625-2634, 2010.
21. Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 267:316-317, 1995.
22. Mosse YP, Balis FM, Lim MS, et al: Efficacy of crizotinib in children with relapsed/refractory ALKdriven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study. J Clin Oncol 30: 606s, 2012 (suppl; abstr 9500).
23. Hostetter MK: What we don't see. N Engl J Med 366:1328-1334, 2012.
24. Gelijns AC, Gabriel SE: Looking beyond translation: Integrating clinical research with medical practice. N Engl J Med 366:1659-1661, 2012.
25. Abernethy AP, Etheredge LM, Ganz PA, et al: Rapid-learning system for cancer care. J Clin Oncol 28:4268-4274, 2010.
26. Coleman MP: Letter from America. Lancet 379:1288, 2012.
27. Ward E, Halpern M, Schrag N, et al: Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58:9-31, 2008.
28. Peabody F: The care of the patient. JAMA 88:877-882, 1927.